Treatment with piperacillin-tazobactam and false-positive Aspergillus galactomannan antigen test results for patients with hematological malignancies.
about
Galactomannan detection for invasive aspergillosis in immunocompromised patientsGalactomannan detection for invasive aspergillosis in immunocompromized patientsDetection of Aspergillus galactomannan antigenemia to determine biological and clinical implications of beta-lactam treatments.Development and optimization of quantitative PCR for the diagnosis of invasive aspergillosis with bronchoalveolar lavage fluid.Pulmonary aspergillosis as opportunistic mycoses in a cohort of human immunodeficiency virus-infected patients: Report from a tertiary care hospital in North India.Reduction in false-positive Aspergillus serum galactomannan enzyme immunoassay results associated with use of piperacillin-tazobactam in the United StatesAspergillus infections in transplant recipients.Early Diagnosis of Invasive Aspergillosis in Neutropenic Patients. Comparison between Serum Galactomannan and Polymerase Chain Reaction.Use of real-time PCR to process the first galactomannan-positive serum sample in diagnosing invasive aspergillosis.Fungal diagnostics in pneumoniaImmunoproteome of Aspergillus fumigatus using sera of patients with invasive aspergillosisOccurrence and kinetics of false-positive Aspergillus galactomannan test results following treatment with beta-lactam antibiotics in patients with hematological disorders.Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis.Update on the laboratory diagnosis of invasive fungal infectionsGalactomannan antigenemia after infusion of gluconate-containing Plasma-Lyte.Aspergillus-Specific Lateral-Flow Device and Real-Time PCR Testing of Bronchoalveolar Lavage Fluid: a Combination Biomarker Approach for Clinical Diagnosis of Invasive Pulmonary Aspergillosis.Management of invasive pulmonary aspergillosis in non-neutropenic critically ill patientsPlasmalyte: No Longer a Culprit in Causing False-Positive Galactomannan Test ResultsGalactomannan antigen detection in the diagnosis of invasive aspergillosis.Advances in the serological diagnosis of invasive Aspergillus infections in patients with haematological disorders.Nosocomial fungal infections: epidemiology, diagnosis, and treatment.Serum galactomannan assay for diagnosis of probable invasive Aspergillosis in acute leukemia and hematopoietic stem cell transplantation.Development of a Lateral Flow Immunoassay for the Rapid Diagnosis of Invasive Candidiasis.Detection of galactomannan antigenemia in patients receiving piperacillin-tazobactam and correlations between in vitro, in vivo, and clinical properties of the drug-antigen interactionFalse-positive Aspergillus galactomannan enzyme-linked immunosorbent assay results in vivo during amoxicillin-clavulanic acid treatment.Primary antifungal prophylaxis in adult hematopoietic stem cell transplant recipients: current therapeutic concepts.Current status and future perspectives on molecular and serological methods in diagnostic mycology.Invasive aspergillosis in hematopoietic stem cell and solid organ transplantation.Emerging moulds: epidemiological trends and antifungal resistance.Diagnosing invasive fungal disease in critically ill patients.Diagnosing invasive fungal diseases - limitations of microbiological diagnostic methods.Utility of galactomannan antigen detection in bronchoalveolar lavage fluid in immunocompromised patients.Utility of bronchoalveolar lavage fluid galactomannan alone or in combination with PCR for the diagnosis of invasive aspergillosis in adult hematology patients: a systematic review and meta-analysis.The use of biomarkers and molecular methods for the earlier diagnosis of invasive aspergillosis in immunocompromised patients.False-positive results by the platelia Aspergillus galactomannan antigen test for patients treated with amoxicillin-clavulanate.Comparison of galactomannan detection, PCR-enzyme-linked immunosorbent assay, and real-time PCR for diagnosis of invasive aspergillosis in a neutropenic rat model and effect of caspofungin acetate.Antifungal therapy of murine Aspergillus terreus infection.Reactivity of platelia Aspergillus galactomannan antigen with piperacillin-tazobactam: clinical implications based on achievable concentrations in serum.Generic piperacillin/tazobactam is not associated with galactomannan false-positivity in adult patients with cancer: a case-control study.Case report: Enteral nutritional supplement as a likely cause of false-positive galactomannan testing.
P2860
Q24186895-F12265EF-FAB1-42D5-A43D-18513227F9EFQ24240734-00DB76AD-F8E2-482C-8668-43749411911AQ24533425-EC808F61-A2A1-43EB-8E7E-5CA8923A1539Q33338675-6BC69E9B-9FA1-4BCB-B670-F2D1E1336242Q33662384-68F9474C-D185-40C5-A2A1-033D291FDEA0Q33703566-78CAA605-06AA-47E5-9039-B30C100D69DCQ33719294-F760B641-430B-4DEF-AE21-6D0C395A05FFQ34052696-8A3F9295-D0C3-4DAB-9EF1-F436ECA62C9EQ34073294-2E4FE6C1-D843-403A-BFC9-54F679E50617Q34153565-354D640A-A5E7-4369-80DD-87649A3A3542Q34158642-6752F902-BE50-486F-90EF-CAF5A59AE85AQ34430636-8B7D94CD-DC47-4353-B8C7-55267691C4ADQ34514484-F5AF83D5-23E7-42E5-8D8C-98410A920824Q35010667-CE8BB4F6-5E2E-47D2-A403-1978B9251D7DQ35598876-D83BD2B4-ABDE-4D5A-8923-0F234AA82E62Q35757644-F627C1D8-AF2A-41FC-87F9-CC5461F4823DQ36087577-0550AF90-22BC-41B1-91BE-47E5C1B7D888Q36620879-C2D88863-65AC-495E-837E-808847B3D804Q36691715-19178A67-3D5D-4D72-B4D4-63E3E942C679Q36774247-FB28E063-D76E-435D-8760-96ACBDE1F935Q36825717-0841DE98-BDD3-4BCD-8BA6-88D6C0BC80EAQ37150921-10A6595D-3DBB-4FC4-BF9B-BB27CD6483C4Q37250318-91612D40-6155-4608-BFC6-C40AA823FDCAQ37576198-D5A25FA4-062E-41B7-9CF1-5E3A960743CEQ37597610-CDED2B80-3152-4E9C-8CC5-D1A82E3D5530Q37621550-128E1B15-7E52-4F6F-BA48-9408840EA673Q37628677-964CF772-0CFE-4F62-9181-13F5CDEA9073Q37854721-A6FB3F99-4A01-4237-AC8C-05D08395C5BEQ37889387-3BB4C72B-0D62-4C36-85F8-4AAAB3B8AABAQ37900310-2E830D4D-08F7-4C53-A411-E7FBE3EF6158Q38088858-78842FAA-0700-4229-8BAE-7DB35A3EE685Q38089915-96FBE840-7CFD-4C99-8F17-398C7B6900A6Q38116964-53CE8753-2DFD-47EF-80E5-644211089BC9Q38508539-3F0E8246-FCB7-4FEF-AE6C-972E7986D155Q39755727-1F9AA20B-DF2C-4D41-BE4F-E80EB745D27BQ39803414-CAD8AA3F-E870-4A6D-BA48-0919F80D73ACQ40164992-99868CAA-D97A-4762-ACB9-E7804DE7A840Q40882839-07984434-8B4C-4FE2-9C01-C1F02C8B1C6EQ41038249-D844915A-899F-4D52-8AD1-84E9349205DCQ41969829-C66113B7-6B11-4112-972C-138A9C4DA23B
P2860
Treatment with piperacillin-tazobactam and false-positive Aspergillus galactomannan antigen test results for patients with hematological malignancies.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Treatment with piperacillin-ta ...... th hematological malignancies.
@en
Treatment with piperacillin-ta ...... th hematological malignancies.
@nl
type
label
Treatment with piperacillin-ta ...... th hematological malignancies.
@en
Treatment with piperacillin-ta ...... th hematological malignancies.
@nl
prefLabel
Treatment with piperacillin-ta ...... th hematological malignancies.
@en
Treatment with piperacillin-ta ...... th hematological malignancies.
@nl
P2093
P356
P1476
Treatment with piperacillin-ta ...... th hematological malignancies.
@en
P2093
Anne Aupérin
Bertrand Gachot
Elisabeth Chachaty
Fanny Wilquin
Jean-Henri Bourhis
Olivier Adam
P304
P356
10.1086/383148
P407
P577
2004-02-27T00:00:00Z